Learn more

ALTERGON SA

Overview
  • Total Patents
    322
  • GoodIP Patent Rank
    10,080
  • Filing trend
    ⇧ 60.0%
About

ALTERGON SA has a total of 322 patent applications. It increased the IP activity by 60.0%. Its first patent ever was published in 1987. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and medical technology are PERITECH PHARMA LTD, HUNAN MEIZAI MEITIAN HEALTH TECH CO LTD and CHULLIEL NEELAKANDAN NARAYANAN.

Patent filings per year

Chart showing ALTERGON SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Schiraldi Chiara 60
#2 De Rosa Mario 59
#3 Marchiorri Maurizio 53
#4 Zoppetti Giorgio 47
#5 Fossati Tiziano 45
#6 Bellorini Lorenzo 36
#7 Bernareggi Alberto 32
#8 Pizzutti Marco 31
#9 Carucci Simone 29
#10 Pontiggia Marco 29

Latest patents

Publication Filing date Title
WO2021059117A1 Plunger for a syringe-type pump for a machine for encapsulation of soft capsules, and syringe-type pump comprising one or more of said plungers
US2020276112A1 Administration regimen of compositions of t4 thyroid hormone with high oral absorption
EP3810252A1 Hollow microneedle for transdermal delivery of active molecules and/or for the sampling of biological fluids and manufacturing method of such hollow microneedle
IT201900003013A1 Administration regimen of T4 thyroid hormone compositions with high oral absorption
IT201900000367A1 COMPOSITIONS INCLUDING A PEPTIDE ABLE TO STIMULATE THE GPRC6A-DEPENDENT SIGNAL PATH
CA3084280A1 Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processes
CN111511381A Use of plant extracts as active agents for the treatment of skin disorders
CN111315813A Absorbable implantable devices based on crosslinked glycosaminoglycans and methods of making the same
IT201800007683A1 Synergistic cooperative compositions useful for soft tissue augmentation, drug release and related fields
US2020086102A1 Device for transdermal delivery of active molecules, uses of the device and methods for producing the device and its components
IT201800003615A1 Highly stable formulations of thyroid hormone in soft capsules
IT201700015145A1 High stability soft gelatin capsules
CA3007592A1 Soft gelatin capsules with ph-independent release
EP3311844A1 High-stability packaged solutions of t4 thyroid hormone
IT201600079328A1 Improved method for the decontamination of biological material by partition and inactivation
BR112017025577A2 methods, holders and kits for enhanced cgh analysis
CN107635546A The liquid pharmaceutical formulation of tetraiodothyronine
ITUB20161027A1 Oromucosal pharmaceutical preparations with high bioavailability based on cyclodextrin and sucralose
ITUB20152542A1 OPHTHALMIC FORMULATIONS BASED ON COOPERATIVE COMPLEXES OF HYALURONIC ACID LOW AND HIGH MOLECULAR WEIGHT
HUE041829T2 Method for closing bottle and associated closed bottle